Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

A novel approach toward development of a rapid blood test for breast cancer.

Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, Perry RR, Wright GL Jr, Semmes OJ.

Clin Breast Cancer. 2003 Aug;4(3):203-9.

PMID:
14499014
2.

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW.

Clin Chem. 2002 Aug;48(8):1296-304.

3.

Surfaced-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) differentiation of serum protein profiles of BRCA-1 and sporadic breast cancer.

Becker S, Cazares LH, Watson P, Lynch H, Semmes OJ, Drake RR, Laronga C.

Ann Surg Oncol. 2004 Oct;11(10):907-14. Epub 2004 Sep 20.

PMID:
15383419
4.

Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.

Lei L, Wang XJ, Zheng ZG, Huang J, Cao WM, Chen ZH, Shao XY, Cai JF, Ye WW, Lu HY.

Anat Rec (Hoboken). 2011 Jun;294(6):941-4. doi: 10.1002/ar.21399. Epub 2011 May 4.

5.

Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.

Gourin CG, Moretz WH 3rd, Weinberger PM, Xia ZS, Liu Z, Terris DJ, Adam BL.

Arch Otolaryngol Head Neck Surg. 2007 Nov;133(11):1125-30.

PMID:
18025317
6.

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.

Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b.

PMID:
18391596
7.

Serum protein profiles in myasthenia gravis.

Cheng C, Wu G, Yeung SC, Li R, Bella AE, Pang J, Zhong FT, Luo H, Jin Y, Pan J.

Ann Thorac Surg. 2009 Oct;88(4):1118-23. doi: 10.1016/j.athoracsur.2009.05.032.

PMID:
19766792
8.

[Establish predictive model of colorectal cancer by using surface enhanced laser desorption/ionization-time of flight-mass spectrometry].

Lai YH, Xu JM, Yu XZ, Zhong YS, Wei Y, Ren L, Zhu DX, Liu YK, Niu WX, Qin XY.

Zhonghua Wai Ke Za Zhi. 2008 Jul 1;46(13):995-7. Chinese.

PMID:
19035201
9.

Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.

Callesen AK, Vach W, Jørgensen PE, Cold S, Tan Q, Depont Christensen R, Mogensen O, Kruse TA, Jensen ON, Madsen JS.

J Proteome Res. 2008 Apr;7(4):1419-26. doi: 10.1021/pr7007576. Epub 2008 Feb 28.

PMID:
18303830
10.

Application of serum SELDI proteomic patterns in diagnosis of lung cancer.

Yang SY, Xiao XY, Zhang WG, Zhang LJ, Zhang W, Zhou B, Chen G, He DC.

BMC Cancer. 2005 Jul 20;5:83.

11.

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.

Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ.

Oncology. 2005;68(1):79-86. Epub 2005 Apr 8.

PMID:
15864000
12.

Diagnosis of gastric cancer using decision tree classification of mass spectral data.

Su Y, Shen J, Qian H, Ma H, Ji J, Ma H, Ma L, Zhang W, Meng L, Li Z, Wu J, Jin G, Zhang J, Shou C.

Cancer Sci. 2007 Jan;98(1):37-43.

13.

Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.

Wang Q, Li D, Zhang W, Tang B, Li QQ, Li L.

Int J Biol Markers. 2011 Oct-Dec;26(4):262-73. doi: 10.5301/JBM.2011.8616.

PMID:
21928244
16.

[Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics].

Chen YD, Xie PP, Yu JW, Zhou J, Zheng S.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Sep;38(5):470-7. Chinese.

PMID:
19830859
17.

Mass spectrometry and serum pattern profiling for analyzing the individual risk for endometriosis: promising insights?

Wölfler MM, Schwamborn K, Otten D, Hornung D, Liu H, Rath W.

Fertil Steril. 2009 Jun;91(6):2331-7. doi: 10.1016/j.fertnstert.2008.03.064. Epub 2008 Jun 13.

PMID:
18555242
18.

Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.

Liu W, Li X, Ding F, Li Y.

Scand J Rheumatol. 2008 Mar-Apr;37(2):94-102. doi: 10.1080/03009740701747152.

PMID:
18415765
19.

[Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry].

Wang YS, Shen J, Yu JK, Zhang L, Ma JL, You WC, Pan KF.

Zhonghua Yu Fang Yi Xue Za Zhi. 2008 Sep;42(9):677-80. Chinese.

PMID:
19175180
20.

Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.

de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M, Merville MP.

Arthritis Rheum. 2005 Dec;52(12):3801-12.

Supplemental Content

Support Center